Tinea and Onychomycosis

被引：2
作者：
Rosen, Theodore [1 ]
机构：
[1] Baylor Coll Med, Dermatol, Houston, TX USA
来源：
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY | 2016年 / 35卷
关键词：
Efinaconazole; luliconazole; naftifine; onychomycosis; tavaborole; tinea pedis; TOENAIL ONYCHOMYCOSIS; DOUBLE-BLIND; FOLLOW-UP; TREATING ONYCHOMYCOSIS; TOPICAL SOLUTION; OZONE GAS; EFFICACY; SAFETY; DERMATOPHYTES; MULTICENTER;
D O I：
10.12788/j.sder.2016.035
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Onychomycosis and tinea pedis are common fungal infections affecting the nails and feet, respectively. Two newly approved topical agents for onychomycosis are efinaconazole and tavaborole, both of which have demonstrated respectable cure rates in clinical studies. For tinea pedis, naffifine 2% and luliconazole 1% are new agents, both administered for relatively short courses, that may foster greater adherence (C) 2016 published by Frontline Medical Communications
引用
收藏
页码：S110 / S113
页数：4
相关论文
共 35 条
  • [1] [Anonymous], 2014, SPOR PRESCR INF
  • [2] [Anonymous], 2015, NOX PRESCR INF
  • [3] [Anonymous], 2016, JUBL PRESCR INF
  • [4] [Anonymous], 2006, PENL PRESCR INF
  • [5] [Anonymous], 2014, KER PRESCR INF
  • [6] [Anonymous], 2015, LAM PRESCR INF
  • [7] Braätigam M, 1998, BRIT MED J, V317, P1084, DOI 10.1136/bmj.317.7165.1084
  • [8] De Cuyper C, 1999, BRIT J DERMATOL, V141, P15
  • [9] Del Rosso James Q, 2014, J Clin Aesthet Dermatol, V7, P13
  • [10] A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis
    Elewski, B.
    Pollak, R.
    Ashton, S.
    Rich, P.
    Schlessinger, J.
    Tavakkol, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) : 389 - 398
1234